Turning Point Therapeutics, Inc. Operating Lease Cost
Turning Point Therapeutics, Inc. reported Operating Lease Cost of $1.00 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2022-08-08
- Turning Point Therapeutics, Inc. operating lease, cost for the quarter ending 2022-06-30 was $1.00M, a 66.67% increase year-over-year.
- Turning Point Therapeutics, Inc. operating lease, cost for the quarter ending 2022-03-31 was $1.00M, a 150.00% increase year-over-year.
- Turning Point Therapeutics, Inc. operating lease, cost for the quarter ending 2021-06-30 was $600.00K.
- Turning Point Therapeutics, Inc. operating lease, cost for the quarter ending 2021-03-31 was $400.00K.
- Turning Point Therapeutics, Inc. operating lease, cost for fiscal 2021 was $2.80M, a 86.67% increase from fiscal 2020.
- Turning Point Therapeutics, Inc. operating lease, cost for fiscal 2020 was $1.50M, a 36.36% increase from fiscal 2019.
- Turning Point Therapeutics, Inc. operating lease, cost for fiscal 2019 was $1.10M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 12 month |
|---|---|---|---|
| 2022-06-30 | $1.00M 10-Q · filed 2022-08-08 | $2.00M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $1.00M 10-Q · filed 2022-05-10 | ||
| 2021-12-31 | $2.80M 10-K · filed 2022-02-28 | ||
| 2021-06-30 | $600.00K 10-Q · filed 2022-08-08 | $1.00M 10-Q · filed 2022-08-08 | |
| 2021-03-31 | $400.00K 10-Q · filed 2022-05-10 | ||
| 2020-12-31 | $1.50M 10-K · filed 2022-02-28 | ||
| 2019-12-31 | $1.10M 10-K · filed 2022-02-28 |